Meet suzetrigine, a non-opioid that promises to avoid addiction risk. But some experts say it can't replace opioids ...

The slaying of Sam “The Punisher” Abdulrahim is the latest in a long list of killings that are as Melbourne as laneway ...

The Food and Drug Administration has approved Journavx (suzetrigine) for the treatment of moderate to severe acute pain in adults.

Drug overdoses have claimed the lives of countless people, including some of our greatest stars. Judy Garland One of the The ...

Should the Seahawks extend Geno Smith? How can the Bears best support Caleb Williams? Kevin Patra identifies one key ...

The new FDA-approved pain drug is suzetrigine, with the brand name Journavx. Suzetrigine is designed to alleviate moderate to ...

The opioid epidemic continues to affect hundreds of thousands of people, but there may be hope for the future with a new, non ...

The first shot taken at Medicaid, likely UnitedHealthcare coverage for Vertex's pain drug, and Optum’s wellness visit ad.

Introducing Journavx: the FDA-approved non-opioid, non-addictive drug for acute pain. A major breakthrough in pain medication ...

The FDA approved an oral combination of meloxicam and rizatriptan (Symbravo) to treat adults with acute migraine with or ...

For years, Judy Chang has been a leader in the movement for drug-user rights. Since 2017, she’s served as executive director of INPUD, the International Network of People Who Use Drugs. The peer-based ...

Most Advantage plans have a drug list, called a formulary. A person can check with their plan’s formulary to find out if Xarelto is covered. Medicare Part D covers prescription drugs.